Acadia Pharmaceuticals
ACAD
ACAD
227 hedge funds and large institutions have $3.61B invested in Acadia Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 74 increasing their positions, 73 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 212 → 227 (+15)
1% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 73
Holders
227
Holding in Top 10
6
Calls
$54.4M
Puts
$40.3M
Top Buyers
| 1 | +$69M | |
| 2 | +$30.9M | |
| 3 | +$27.8M | |
| 4 |
SIG
Senator Investment Group
New York
|
+$26M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$25.3M |
Top Sellers
| 1 | -$39.2M | |
| 2 | -$39.2M | |
| 3 | -$35.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.4M |